Filing Flows › Comparisons › FEMY vs MBOT
Femasys vs Microbot Medical: FEMY and MBOT compared
Femasys is the larger company: $332K of revenue in its latest quarter (Q2 2026) against $241K for Microbot Medical (Q2 2026).
Where the money goes: FEMY and MBOT
Femasys (FEMY) · Q2 2026
Femasys, Q2 2026: revenue $332K (-19% year over year), net loss $4.5M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
Microbot Medical (MBOT) · Q2 2026
Microbot Medical, Q2 2026: revenue $241K, net loss $5.6M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
| Femasys (FEMY) | Microbot Medical (MBOT) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $332K | $241K |
| Revenue growth, Y/Y | -19% | — |
| Operating margin | n/m | n/m |
| Net earnings | −$4.5M | −$5.6M |
| Operating cash flow | −$3.9M | −$5.0M |
Questions
Which is bigger, Femasys or Microbot Medical?
Femasys is the larger company: $332K of revenue in its latest quarter (Q2 2026) against $241K for Microbot Medical (Q2 2026).
More: Femasys earnings · how Femasys makes money · Microbot Medical earnings · how Microbot Medical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.